Evidence map›Paper›PMID 37388463›Full record

ArticleCurrent clinical microbiology reports2023

Genetic Diversity of Human Fungal Pathogens.

Jillian Freese, Sinem Beyhan

Abstract read
In one paragraph

Article in Current clinical microbiology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Pathogenic diversity ofCell surface (Amsterdam, Netherlands) · 2025
    Article
  2. Article
  3. Article
  4. Analyses of the Genetic Diversity and Population Structures ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jillian FreeseDepartment of Infectious Diseases, J. Craig Venter Institute, La Jolla, CA 92037, USA.
Sinem BeyhanDepartment of Infectious Diseases, J. Craig Venter Institute, La Jolla, CA 92037, USA.

Funding

Innate immune mechanisms of the host response to CoccidioidesU19AI166059 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Joshua Fierer · 2022 to 2026
$10.0M
Interplay between the heat shock response and histidine kinase pathways in the thermally dimorphic fungal pathogen Histoplasma capsulatumR01AI137418 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI BEYHAN, SINEM · 2018 to 2023
$2.4M
NCEZID CDC HHS U54 CK000603NIAID NIH HHS R01 AI137418NIAID NIH HHS U19 AI166059
6 · The paper itself

Abstract

Purpose of review: Fungi represent a central yet often overlooked domain of clinically relevant pathogens that have become increasingly important in human disease. With unique adaptive lifestyles that vary widely across species, human fungal pathogens show remarkable diversity in their virulence strategies. The majority of these fungal pathogens are opportunistic, primarily existing in the environment or as commensals that take advantage of immunocompromised hosts to cause disease. In addition, many fungal pathogens have evolved from non-pathogenic lifestyles. The extent of genetic diversity and heritability of virulence traits remains poorly explored in human fungal pathogens. Recent findings: Genetic variation caused by mutations, genomic rearrangements, gene gain or loss, changes in ploidy, and sexual reproduction have profound effects on genetic diversity. These mechanisms contribute to the remarkable diversity of fungal genomes and have large impacts on their prevalence in human disease, virulence, and resistance to antifungal therapies. Summary: Here, we focus on the genomic structure of the most common human fungal pathogens and the aspects of genetic variability that contribute to their dominance in human disease.

Indexed as

AspergillusCandidaCryptococcusendemic fungal pathogensfungal genome

Identifiers

PMID37388463
PMCPMC10310308

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.